首页> 美国卫生研究院文献>Medicina >Systemic Mastocytosis and Essential Thrombocythemia: Case Report and Literature Overview
【2h】

Systemic Mastocytosis and Essential Thrombocythemia: Case Report and Literature Overview

机译:系统性肥大细胞增多症和原发性血小板增多症:病例报告和文献综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mastocytosis is a rare disease in which heightened amounts of mast cells accumulate in the skin, bone marrow, and other visceral organs. Upon activation, mast cells release a wide variety of preformed or newly synthesized mediators which can induce allergic symptoms and inflammatory reactions. Mastocytosis is diagnosed by biopsy and can be divided into cutaneous and systemic mastocytosis (SM). The first one affects the skin and is relatively benign, whilst SM, which involves bone marrow and other organs, may be aggressive and associate with both myelodisplastic and myeloproliferative diseases. Here we present a case of SM associated with essential thrombocythemia and complicated by severe osteoporosis, successfully treated with hydroxyurea, low-dose aspirin and zolendronic acid.
机译:肥大细胞增多症是一种罕见的疾病,其中肥大细胞数量增加,聚集在皮肤,骨髓和其他内脏器官中。激活后,肥大细胞释放各种预先形成的或新合成的介体,这些介体可以诱发过敏性症状和炎症反应。肥大细胞增多症可以通过活检诊断出来,可以分为皮肤性和全身性肥大细胞增多症(SM)。第一个影响皮肤并且相对良性,而涉及骨髓和其他器官的SM可能具有侵略性,并与骨髓增生性疾病和骨髓增生性疾病相关。在这里,我们介绍了一个与原发性血小板增多症并发严重骨质疏松症并发的SM病例,已成功用羟基脲,小剂量阿司匹林和唑来膦酸治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号